Valuation: ResMed, Inc.

Market Cap 2.94TCr 2.58TCr 2.39TCr 2.2TCr 4.16TCr 2,81500Cr 4.24TCr 28TCr 11TCr 1,38200Cr 11TCr 11TCr 4,77300Cr P/E 2026 *
19.3x
P/E 2027 * 17.2x
Enterprise Value 2.86TCr 2.5TCr 2.32TCr 2.13TCr 4.04TCr 2,73300Cr 4.12TCr 28TCr 11TCr 1,34200Cr 11TCr 10TCr 4,63500Cr EV / Sales 2026 *
5.05x
EV / Sales 2027 * 4.54x
Free-Float
75.61%
Yield 2026 *
1.19%
Yield 2027 * 1.29%
1 day-3.05%
1 week-9.55%
Current month+1.37%
1 month+2.50%
3 months-14.21%
6 months-22.43%
Current year-17.98%
1 week 190.25
Extreme 190.25
219.98
1 month 184.65
Extreme 184.65
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
07/07Fiscal year

Chief Executive Officer

14,973 0.0103%
08/06Fiscal year

Chief Executive Officer

14,973 0.0103%
01/06Tax

General Counsel

-269 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-3.00%-9.55%-22.26%-9.67% 2.94TCr
+0.37%+2.43%+24.65%+0.67% 20TCr
+0.75%-5.32%-20.65%+18.11% 14TCr
+0.45%+3.26%+1.10%-16.28% 14TCr
+0.16%+0.38%-57.09%-15.19% 6.65TCr
-0.43%-3.46%+17.38%-1.29% 5.31TCr
+2.80%+1.95%-22.68%-30.55% 4.41TCr
-0.91%+2.12%+11.07%+11.75% 3.79TCr
-1.11%-1.41%+22.81%+38.73% 3.7TCr
+1.23%+1.00%-12.03%-19.55% 2.94TCr
Average -0.02%-0.95%-5.77%-2.33% 7.78TCr
Weighted average by Cap. +0.25%-0.90%-2.07%-1.24%

Financials

2026 *2027 *
Net sales 565.01Cr 495.57Cr 458.99Cr 422.33Cr 798.81Cr 54TCr 814.35Cr 5.47TCr 2.15TCr 27TCr 2.12TCr 2.08TCr 92TCr 610.1Cr 535.12Cr 495.62Cr 456.02Cr 862.55Cr 58TCr 879.34Cr 5.91TCr 2.32TCr 29TCr 2.29TCr 2.24TCr 99TCr
Net income 154.8Cr 135.77Cr 125.75Cr 115.7Cr 218.85Cr 15TCr 223.11Cr 1.5TCr 587.82Cr 7.28TCr 581.27Cr 568.57Cr 25TCr 170.74Cr 149.76Cr 138.7Cr 127.62Cr 241.39Cr 16TCr 246.09Cr 1.65TCr 648.37Cr 8.03TCr 641.15Cr 627.13Cr 28TCr
Net Debt -85Cr -74Cr -69Cr -63Cr -120.05Cr -8.13TCr -122.38Cr -822.12Cr -322.44Cr -3.99TCr -318.85Cr -311.88Cr -14TCr -168.53Cr -147.82Cr -136.91Cr -125.97Cr -238.27Cr -16TCr -242.9Cr -1.63TCr -639.98Cr -7.92TCr -632.85Cr -619.01Cr -27TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
13/26/13 $197.55 -3.10% 10,74,506
10/26/10 $203.87 -2.20% 13,31,149
09/26/09 $208.45 +1.27% 14,79,036
08/26/08 $205.84 -6.33% 17,61,755
07/26/07 $219.75 +0.62% 17,26,352
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
203.87USD
Average target price
253.73USD
Spread / Average Target
+24.46%

Quarterly revenue - Rate of surprise